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1. INTRODUCTION 
The Commission have discussed on several occasions with the Member States and 
the European Parliament about the next steps in the BSE policy on different points 
such as SRM, feed ban and age of testing.  
We have come to the stage that amendments of certain measures could be envisaged 
if the positive trend continues and scientific conditions are in place without 
endangering the health of the consumer or the policy to eradicate BSE. Indeed 
different indicators already suggest a favourable trend in the BSE epidemic and a 
clear improvement of the situation in recent years due to the risk reducing measures 
in place. Furthermore inspection reports indicate that implementation of BSE 
requirements in the Member States has improved. The main indicators are presented 
in the charts 1 -3 in Annex I.  
There is a significant overall decrease in the number of cases of the disease across 
the EU (about 850 BSE cases in 2004 in the EU 25 compared to 2129 BSE cases 
in 2002 in the EU 15). It clearly demonstrates the downward trend of positive BSE 
cases detected over the last four years with a 35 % reduction since 2002.The decrease 
in the number of cases by birth cohort since 1996 is presented in the chart I in 
Annex I.  
The chart 2 in Annex I shows the year of birth of the positive BSE cases detected 
since 2001 excluding UK. The top of the curve and subsequent downward trend 
indicate the main contamination through feed in the years 1994 – 1995 followed by a 
sharp decrease due to the BSE measures taken e.g. partial feed ban in 1994 and total 
feed ban in 2001. The impact of the 2001 total feed ban can only be assessed in the 
coming years due to the mean incubation period of BSE of 6 – 8 years. 
The chart 3 in Annex I illustrates that the mean age of the positive cases in healthy 
slaughtered animals in EU 15 increased between 2001 to 2004 from 76.2 months to 
95.0 months of age; in 2004, the mean age of the positive cases in healthy 
slaughtered animals in the new member states was 79.9 months. This indicates 
contamination during a well defined period in the past well before the stringent BSE 
measures came into force at Community level.  
Based on the improved situation, the Commission has taken this initiative to present 
a road map on the BSE strategy in the short, medium and long term.  
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Any relaxation following the scientific assessment should be initiated by an open 
discussion with all stakeholders and supported by a strong communication strategy. 
Bearing in mind the political consequences following the first and second BSE crisis 
any relaxation although scientifically justified may call upon the political courage of 
the Member states to reduce the current measures in place. In setting our strategy the 
greatest importance is attached to maintaining the high level of consumer protection 
built up over the years in the field of prevention, control and eradication of the 
transmissible spongiform encephalopathies. However, in this process it is also 
important not to lose sight of other threats to animal and public health which have 
emerged in recent years, including diseases such as SARS and new variants of avian 
influenza. The balance of evidence is increasingly pointing towards the need to re-
consider the current priorities in the field of food safety and animal health. The 
encouraging trends in relation to BSE merit a considered review of the opportunities 
to focus on these new threats.  
2. AMENDMENTS IN THE SHORT AND MEDIUM TERM (2005 - 2009).  
2.1. Specified Risk Material  
Strategic goal:  
To ensure and maintain the current level of consumer protection by continuing 
to assure safe removal of SRM but modify list/age based on new & evolving 
scientific opinion 
2.1.1. Current legislation 
Specified risk material is the most important public health protection measure. The 
initial list of SRM was established based on the scientific knowledge before 1995 
and the precautionary principle. Since then, the overall situation has been improved 
and new scientific data has become available. The restrictions on the use of SRM 
include a prohibition to use such products for the production of derived products for 
use in food and feed such as tallow, gelatine, collagen and dicalcium phosphate. 
2.1.2. Future policy option 
Any amendment of the current list of specified risk material should be based on new 
evolving scientific knowledge while maintaining the existing high level of consumer 
protection within the European Union. In addition, data from BSE active monitoring 
and surveillance should also be used to revise SRM policies. 
On 27-28 April 2005 the European Food Safety Authority (EFSA) adopted an 
opinion on SRM supporting an increase of the current age limit for central nervous 
tissue from 12 to 21 or 30 months depending the value given to the extremely rare 
BSE cases detected in young animals. This opinion allows for reflection on an 
amendment of the current SRM list and in particular on the age limit for the removal 
of the vertebral column as a first step.  
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The list of SRM in small ruminants depends on the outcome of the risk assessment 
currently being carried out by EFSA.  
Pending scientific advice on tallow, collagen and gelatine processing standards for 
those commodities will be further refined with possible relaxation compared to the 
current requirements.  
2.2. Feed Ban  
Strategic goal:  
A relaxation of certain measures of the current total feed ban when certain 
conditions are met  
2.2.1. Current legislation  
A ban on the feeding of mammalian meat and bone meal (MBM) to cattle, sheep and 
goats was introduced as of July 1994. This partial ban was extended to a total EU 
wide suspension on the use of processed animal protein in feeds for any animals 
farmed for the production of food on 1 January 2001 with some exceptions like the 
use of fish meal for non-ruminants. Any presence of prohibited constituents of 
animal origin in feed is considered as a breach of the feed ban i.e. the zero-tolerance.  
2.2.2. Future policy option  
The starting point when revising the current feed ban provisions should be risk-based 
but at the same time taking into account the control tools in place to evaluate and 
ensure the proper implementation of this feed ban.  
2.2.2.1. Environmental contamination (beet pulp) 
Analyses in Germany demonstrate that presence of bones in beet pulp is frequent (up 
to 10%) and cannot be avoided. The likely origin is bone fragments of wild animals 
in soil which stick to the beets and end up in sugar beet pulp fed to ruminants. The 
introduction of a tolerance on the presence of bone fragments in sugar beet pulp and 
other feedingstuffs due to this environmental contamination is being considered only 
when a robust risk assessment has demonstrated the absence of cross contamination 
or the fraudulent incorporation of meat-and-bone meal (MBM).  
2.2.2.2. Fish meal  
• The use of fishmeal is currently prohibited in feed intended for ruminants and 
there are also important conditions applying to its use in feed intended for non-
ruminants. In order to obtain a more risk based policy, an introduction of a 
tolerance level with regard to a small presence of fishmeal in ruminant feed 
due to cross contamination may be proposed. The purpose of such tolerance is 
to solve the unwanted side effects of the fishmeal ban on the feeding of non-
ruminants while respecting the position of the European Parliament, currently 
against the use of fishmeal in feedingstuffs for ruminants.  
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• The European Parliament is expected to have a general discussion of fishmeal 
mid 2005. A decision on a possible relaxation regarding the fishmeal ban will 
take into consideration the outcome of the discussion in the European 
Parliament. 
2.2.2.3. Lifting feed ban provisions for non-ruminants  
Further improvement in differentiating animal proteins specific to certain species 
may result in an amendment of the provisions with regard to the use in feedingstuffs 
of animal products, in particular non-ruminant proteins taking into account the 
prohibition on intra-species recycling in Regulation (EC) No 1774/2002 (e.g. poultry 
MBM to pigs). Differential tests are already awaited since 2001. The mandatory 
treatment of mammalian proteins at 133°C, 3 Bars during 20 minutes results in very 
small fragments of animal proteins which are hard to detect by the current analytical 
methods. 
Awaiting the validation of discriminatory tests and pending the results of the 
quantitative risk assessment by the EFSA on the risk linked to small amount of 
MBM, an introduction of a tolerance level with regard to a small presence of meat-
and-bone meal in feed may be proposed without jeopardising the current eradication 
measures.  
2.2.2.4. Tallow  
Currently there are no specific restrictions with regard to the use of tallow in feed (or 
food) to prevent transmission of TSEs. The restriction on the use of specified risk 
material is applicable in addition to the mandatory purification of rendered fat at 
0.15% insoluble impurities in Regulation (EC) No 1774/2002. A possible need for 
future provisions on tallow, in particular for use in milk replacers depends on the 
result of the quantitative risk assessment (QRA). 
2.3. Monitoring programmes  
Strategic goal:  
To reduce the numbers of tests of bovine animals and at the same time continue 
to measure the effectiveness of the measures in place with a better targeting of 
the surveillance activity 
2.3.1. Bovine animals  
2.3.1.1. Current legislation  
Up until the middle of 2000, the majority of BSE cases detected were found by 
means of traditional passive surveillance, i.e. through the examination and mandatory 
reporting of animals suspected of showing signs or clinical symptoms of BSE. The 
detection of BSE in healthy slaughtered cattle in 2000 indicated the need for active 
monitoring which was introduced in the whole community in the beginning of 2001. 
The active monitoring programme became fully operational in July 2001 and still 
includes:  
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– The testing of all risk animals over 24 months of age (fallen stock, emergency 
slaughtered animals and animals with clinical signs at ante-mortem inspection)  
– The testing of all healthy slaughtered bovine animals above 30 months of age 
(a total of 10 million cattle per year) 
The table 1 in Annex II gives the number of animals tested since 2001 for the 
different age categories and different categories (healthy slaughter, risk animals, 
fallen stock).  
For countries that have determined that BSE exists within the cattle population, the 
goal of surveillance is monitoring of the effectiveness of control measures such as 
feed ban and SRM removal by following the evolution of BSE prevalence. In 
addition in countries without (recent) BSE cases, the final goal of surveillance is to 
demonstrate that BSE is below an agreed threshold. It should be noted as well that, 
although active BSE monitoring is not a public health protection measure, it has 
contributed to increased consumer confidence and has played a role in the 
communication strategy of certain member states. In addition the surveillance results 
have provided the necessary data to evaluate an amendment of the current list of 
specified risk materials.  
2.3.1.2. Future policy option  
(a) Epidemiological considerations  
 Based on the results of the ongoing monitoring programme and forthcoming 
results of the full testing programmes in the new Member States, a revision of 
the monitoring programme may be envisaged in 2005 in order to lay down a 
strategy which moves from the current testing regime to maintenance 
surveillance based on the CRL model in the long term. Different options for 
such transition should be analysed with epidemiologists and statisticians taking 
into account the above goals and cost benefits. Such options are:  
• The gradual increase of the age limit starting for healthy slaughtered 
animals and fallen stock. The increase of the age would depend on the 
results of the ongoing surveillance programme.  
• A decrease of monitoring of cattle born in years from which statistically 
sufficient information on the BSE prevalence is available but focussing 
on (recent) years of birth from which only limited information is 
available.  
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(b) Cost – benefit considerations  
 Bearing in mind the goal of the surveillance the costs linked to the surveillance 
programme should be weighted against the information received through the 
surveillance. The detailed costs are enclosed as Annex II to this paper. The 
costs include the co-financing by the Commission and the cost financed by the 
Member states1.  
 The table 2 in Annex II gives the costs linked to the finding per positive case 
found in the different age groups. Note that the cost linked to the finding of 
the one positive case in 2002 in healthy slaughter surveillance stream in 
the age group 30 -35 months is 302 Mio EURO.  
2.3.2. Small ruminants  
2.3.2.1. Current legislation  
Apart from the mandatory examination and reporting of sheep and goats suspected of 
showing signs or clinical symptoms of a TSE, an active monitoring programme was 
introduced in the beginning of 2002. Since the confirmation of BSE in a goat in the 
beginning of 2005, the active monitoring includes:  
– The testing of a minimum sample size including up to 10 000 sheep and 10 000 
goats per Member State of risk animals over 18 months of age (fallen stock, 
emergency slaughtered animals and animals with clinical signs at ante-mortem 
inspection)  
– The testing of 10 000 healthy slaughtered ovine animals above 18 months of 
age in Member States with a large population and a minimum, statistically 
based but high number of healthy slaughtered goats over 18 months of age. In 
most Member States all healthy slaughtered goats are tested.  
The current extended monitoring in goats will be reviewed in the second half of 2005 
and allows a fast and better estimate of BSE in goats in order to assess if the positive 
BSE case in the goat born in 2000 and slaughtered in France in 2002 was an isolated 
case.  
2.3.2.2. Future policy option 
Future monitoring in small ruminants depends on the estimated prevalence of BSE in 
such animals based on the results of the current extended monitoring in goats and the 
results from discriminatory testing of new cases and, if possible, analysis of TSE 
cases in the past. In case the results of the ongoing monitoring indicate that the single 
BSE cases found in the goat was an isolated case, monitoring can be reduced or only 
continued for a limited period of time to increase the confidence in the results of the 
increased testing.  
                                                 
1 Average cost of a BSE rapid test is budgeted at 50 EURO with 8 Euro co-financed by the Commission. 
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In the worst case scenario where an increase of BSE cases is detected in the small 
ruminant population, an increase of the surveillance might be envisaged.  
2.3.3. Cervids  
At this moment no measures are foreseen within EU regarding Chronic Wasting 
Disease (CWD. There is no evidence to suggest that CWD has occurred in the EU, or 
at least if it has it must be at a very low prevalence, since otherwise it should be 
expected to have been detected by now. Nor is there any concrete evidence of 
transmission of CWD to humans, or of susceptibility of deer to BSE. If experimental 
or field evidence of either were discovered, this would warrant a change in policy as 
regards CWD. 
Because of the limited surveillance data in EU, a survey will be initiated in the 
beginning of 2006, the goal of which is to confirm the situation. This will be a 
targeted survey, in line with the EFSA opinion. However before starting with the 
survey different risk management measures should be considered during the course 
of survey preparation mainly related to the action following the detection of a 
positive CWD case in cervids taking account of the scientific opinion linked to the 
risk. 
2.4. The categorisation of countries according their BSE risk.  
Strategic goal:  
Simplification of the categorisation criteria and conclude the categorisation of 
the countries before 1 July 2007.  
The objective of a categorisation according to the BSE risk is to define trade rules for 
every risk category which will give the necessary guarantees to protect animal and 
public health for the importing countries. The conditions for such trade are already 
laid down in the current recommendations of the Terrestrial Animal Health Code 
(“Code”) of the World Organisation for Animal health (OIE).  
The current five categorisation criteria in the Code lead to a final BSE status, which 
did not necessarily reflect the real situation. This is because some of the other criteria 
are unnecessarily rigid, and not adapted to the risk. Furthermore the present system 
with five categories is very complicated. It is also not necessary to maintain three 
different categories for countries with a BSE risk, as the trade conditions are largely 
similar. The five categories were introduced in the TSE Regulation, pending 
agreement in the OIE on a revised system. OIE started two years ago a process to 
review and simplify the categorisation of countries according their BSE risk into 
three categories.  
At the General Session in May 2005 an agreement was reached on the simplified 
categorisation procedure including the requirements on surveillance within the 
different categories. The simplified categorisation procedure includes three 
categories:  
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• Category 1: Countries with a negligible BSE risk and a reduced active 
surveillance programme detecting a design prevalence of 1 per 50 000 - 
imports allowed without restrictions;  
• Category 2: Countries with a controlled BSE risk and active surveillance 
programme detecting a design prevalence of 1 per 100 000 – imports allowed 
when SRM removed;  
• Category 3: Countries with an undetermined BSE risk. The country will be 
allowed to export only a limited list of tradable products. 
Based on this new international standard the current provisions under the TSE 
Regulation should be amended. Following adoption of the new categorisation criteria 
the countries should be categorised starting with the major trading partners. If OIE 
does not succeed in categorising the countries before 1 July 2007 the Community 
should categorise the countries according to the new international standard.  
2.5. Review of culling policy with regard to TSEs in small ruminants 
Strategic goal:  
Review and relaxation of the eradication measures for small ruminants taking 
into account the new diagnostic tools available but ensuring the current level of 
consumer protection 
2.5.1. Current legislation 
The current provisions require a whole herd culling if TSE is detected in goats and a 
whole or partial (sensitive genotypes) culling if TSE is detected in sheep including 
atypical cases. In order to improve the genetic resistance within the sheep population 
a minimal breeding programme became mandatory for flocks of high genetic merit 
from 1 April 2005 on. Atypical cases are TSE cases in which BSE is excluded often 
detected by active surveillance without clinical signs, with no or very limited 
spreading in a flock, but present in sheep with genotypes considered resistant to BSE 
(in contrast to classical scrapie). Furthermore the molecular discriminatory testing in 
force since January 2005, may exclude the presence of BSE within a few weeks in 
most TSE cases. When BSE is excluded, a public health risk is no longer present and 
total herd culling might be considered disproportionate on public health grounds. 
The table below gives the number of positives sheep and goats within infected herds  
 Sheep Goats 
2002 1.3% 0.7% 
2003 2.8% 0.3% 
2004 3.5% 1.2% 
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It should be noted that in most flocks no additional cases are detected by culling, in 
particular when atypical cases had been found. In other flocks, a TSE infection was 
demonstrated in up to 40% of the animals. 
2.5.2. Future policy option 
The Commission would like to propose a relaxation of the culling policy for all cases 
where BSE is excluded (sheep and goats) with an increased testing regime within the 
infected flocks and the slaughter for human consumption of all animals of all ages in 
infected herds if negative by rapid testing. Conditions for herd certification should 
also be considered as an additional way of eradicating TSEs.  
2.6. Cohort culling in bovine animals  
Strategic goal: 
To stop the immediate culling of the cohort  
2.6.1. Current legislation 
The current legislation on TSE foresees the killing and destruction (culling) of the 
cohort animals linked to a positive BSE. The cohort animals are animals without any 
symptoms but which are assumed to be a higher risk of being infected with BSE due 
to an epidemiological link. This includes in case of female animals the progeny of 
the positive BSE case (“birth” cohort) or animals which received the same feed as 
the positive animal in the first year of their life (“feed” cohorts).  
2.6.2. Future policy option  
Reflection on alternatives to the current destruction of the cohort can be made. A 
proposed alternative would be to defer the culling and destruction at the end of the 
productive life, as foreseen within the International OIE Animal Health Code or to 
allow the slaughtered animals into the food chain following a negative rapid testing 
result. Although this relaxation would allow breeding and use of milk the decision to 
derogate from the culling should be the responsibility of the Member states in order 
to take into account the potential consequences for their export markets. The 
derogation to defer the culling would be the Member States decision. This relaxation 
would not endanger the current level of consumer protection. A relaxation would not 
only reduce the economical impact but also the social consequences following the 
complete destruction of the cohorts being often one of the main reasons to object to 
the culling policy.  
The table below shows the number of animals culled and tested in 2003 – 2004 and 
the number of positives detected within the cohort animals.  
Year 2003 2004 Total 
Animals tested 25.747 16.471 42.218 
BSE cases 10 5 15 
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In the medium term slaughter for human consumption can be considered subject to a 
negative TSE test, removal of specified risk materials and a decreasing prevalence. 
However, as the BSE prevalence reduces, the cost of culling also reduces and from a 
consumers perception (and trade) point of view the total herd culling for destruction 
may be the preferred option in particular in Member states where BSE was absent or 
very rare. This would be a Member States decision. 
2.7. UK restrictions  
Strategic goal:  
To discuss the lifting of the additional restrictions on exports of beef and beef 
products from the UK if the preset conditions are complied with.  
2.7.1. Current legislation  
Council Decision 98/256/EC (UK embargo Decision) and subsequent amendments 
provides that the United Kingdom is to ensure that live bovine animals and products 
thereof are not dispatched from its territory to other Member States or to third 
countries except under certain specified conditions (deboned, exclusion of cattle aged 
over 30 months etc).  
2.7.2. Future policy option 
In 1996 the United Kingdom introduced the Over-Thirty-Months (OTM) Rule as a 
public health protection measure which bans meat from most cattle aged over 
30 months at slaughter from being destined for human consumption. On 
1 December 2004 the United Kingdom informed the Commission on the decision 
taken to replace the OTM rule with a testing regime as in the other Member States 
and to exclude permanently cattle born before 1 August 1996 from the food and feed 
chain. 
Regarding the possible lifting of the UK embargo different conditions should be in 
place to start the discussion. These include a UK incidence fallen below the 200 BSE 
cases per million adult cattle and a favourable outcome of the audit mission of the 
Food and Veterinary Office (FVO) in June 2005. On the 10 March 2005 the 
European Food Safety Authority (EFSA) confirmed the incidence below 200 BSE 
cases per million adult cattle. 
When both conditions are complied with, in particular a favourable outcome of the 
FVO inspection, a discussion with the Member states on the lifting of the embargo 
could be initiated likely in the fourth quarter of 2005. 
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3. AMENDMENTS ON THE LONG TERM (2009 - 2014) 
Strategic goal:  
To modify measures in line with current technology and new evolving scientific 
knowledge.  
In case the positive trend continues, taking into account the relaxation of the 
measures in the short and medium term, a further relaxation of the measures can be 
envisaged. The use of validated live animal tests may in the future allow tracing and 
culling the positive animals and therefore shortening the period before further 
relaxation measures can be taken. The different options could include: 
3.1. Surveillance  
Different scenarios can be envisaged on the long term:  
– The gradual decrease in the level of surveillance can be maintained if the 
positive trend continues focusing on older animals or on birth cohorts from 
which only limited information is available.  
– If only BSE cases are detected in animals above 10 year i.e. born before 
1 January 2002, it may be decided to exclude those animals permanently from 
the feed and food chain (destruction scheme) and provide financial support for 
the culling of those animals at the end of their productive live. The final 
surveillance strategy would be reduced to the examination of the clinical 
suspect animals (passive surveillance) and a maintenance strategy in line with 
the OIE recommendations.  
– The option to test every animal with a live animal test, if available, at a certain 
age could also be envisaged.  
3.2. Specified risk material  
If BSE cases are not detected below a certain age or drop below an agreed prevalence 
the obligation to remove the specified risk material may be withdrawn within this age 
group. Alternatively, a permanent minimal list of SRM in particular nervous tissues 
(brain, spinal cord) of cattle of certain age groups may be considered as a 
precautionary measure against future epidemics or sporadic cases.  
3.3. Certification of herds  
Following the testing of all cattle with a live animal test a certification of the herd 
status could be introduced in line with the farm certification as it is the case for 
tuberculosis or brucellosis.  
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3.4. Genetic resistance in goat  
In case further research indicates genetic resistance of certain genotypes within the 
goat population the eradication strategy should be reviewed in the light of these new 
developments.  
4. ALTERNATIVE SCENARIOS IF THE POSITIVE TREND DOES NOT CONTINUE  
All indicators regarding the prevalence of BSE in bovine animals suggest that a 
future increase of BSE cases is unlikely. An alternative scenario should be included 
if the positive trend is not confirmed in certain Member states. Furthermore when 
considering a medium and long term strategy regarding small ruminants and cervids 
a possible worst case scenario should also be envisaged. This would include: 
• Non-favourable trend of BSE in certain Member states  
 If the positive trend is not confirmed in certain Member states more stringent 
measures regarding SRM removal compared to the other Member states could 
be envisaged. At the last stage a temporary embargo might be envisaged which 
will allow addressing the situation in the individual Member state without 
penalising the other Member states where the negative trend is not confirmed.  
• BSE in small ruminants 
 If, following the intensive surveillance in goats, BSE would be confirmed at 
large scale within the sheep and goat population stringent measures should be 
taken which would include the full testing of small ruminants and consequently 
discriminatory testing of the TSE cases and an extensive list of SRM based on 
the scientific opinions which could lead in the worst scenario to the complete 
destruction of the carcass.  
 This will also enforce the need for a breeding programme for resistance within 
the sheep population.  
• Chronic Wasting Disease (CWD) in cervids  
 If CWD would be confirmed following the survey planned in 2006 a decision 
on the removal of specified risk material may be permanently in place.  
5. CONCLUSION 
We have come a long way and the Commission has introduced a comprehensive set 
of stringent Community measures. In the last 10 years, the Commission has 
generated 70 primary and implementing acts which set stringent measures at 
Community level. The key piece of legislation to protect human and animal health 
from the risk of BSE and other TSE's was adopted on 22 May 2001. This Regulation 
(EC) No 999/2001 of the European Parliament and of the Council lays down rules 
for the prevention, control and eradication of certain transmissible spongiform 
encephalopathies, and is commonly known as the "TSE Regulation". This Regulation 
was applicable, within a very short time frame, as of 1 July 2001. 
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Different factors indicate a favourable trend in the BSE epidemic and a clear 
improvement of the situation over the past years due to the risk reducing measures in 
place. The goal for the coming years for the TSE regulation is to ensure a relaxation 
of the measures while assuring the high level of food safety introduced through the 
TSE controls over the past 10 years. The relaxation of the measures should be risk 
based and reflect advances in technology as well as evolving scientific knowledge 
and would also have a positive impact on the competitiveness of the industries and 
farmers involved within the Community.  
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6. ANNEX I 
Chart 1: BSE cases from 2001 to 2004 
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Chart 2 : BSE cases by birth cohorts 
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Chart 3: Mean age of positive cases in healthy slaughtered animals in EU 15 
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7. ANNEX II: MONITORING DATA  
Table 1: number of bovine animals tested from January 2001 to December 2004 
Age group Healthy slaughtered Risk animals Fallen Stock 
< 24 months 3.370.000 70.000 55.000 
24-29 3.035.000 455.000 355.000 
30-35 6.715.000 655.000 515.000 
36-41 3.065.000 395.000 310.000 
42-47 months 2.400.000 330.000 260.000 
>= 48 months 17.235.000 3.060.000 2.405.000 
Total 35.820.000 4.965.000 3.900.000 
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Table 2: costs (Mio €) per BSE case detected between January 2001 until December 2004 
Age group Healthy slaughter Risk animals 
<24 months No cases No cases 
24-29 months No cases 10,2 
30-35 months 302 29,5 
36-41 months 69 17,8 
42-47 months 11 0,9 
All <48 months 64 4,3 
All =>48 months 0,76 0,04 
All Ages 1,56 0,07 
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8. ANNEX III: COSTS LINKED TO THE SURVEILLANCE PROGRAMME  
Table 1: estimated age distribution of bovine animals tested from January 2001 to December 2004 
Age group Healthy slaughtered Risk animals (Fallen Stock) 
< 24 months 3.370.000 70.000 55.000 
24-29 3.035.000 455.000 355.000 
30-35 6.715.000 655.000 515.000 
36-41 3.065.000 395.000 310.000 
42-47 months 2.400.000 330.000 260.000 
>= 48 months 17.235.000 3.060.000 2.405.000 
Total 35.820.000 4.965.000 3.900.000 
Table 2: Number of BSE cases in young bovine animals detected from January 2001 until December 2004 
Healthy slaughter Risk animals 
Age group 2001 2002 2003 2004 2001 2002 2003 2004 
< 24 months 0 0 0 0 0 0 0 0 
24-29 months 0 0 0 0 2 0 0 0 
30-35 months 0 1 0 0 0 1 0 0 
36-41 months 0 1 1 0 0 1 0 0 
42-47 months 3 0 2 5 5 1 3 2 
Total < 48 
months 
3 2 3 5 7 3 3 2 
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Table 3: Number of test carried out from January 2001 until December 2004 per detected case 
Age group Healthy slaughter Risk animals 
24-29 months No cases 177.500 
30-35 months 6.715.000 515.000 
36-41 months 1.532.500 310.000 
42-47 months 240.000 16.250 
All ages 34.743 1.572 
      
Table 4: Costs (Mio €) of BSE monitoring between January 2001 until December 2004 
The global costs of BSE testing is estimated at 40-50 € per tests with 45€ is taken as a mean cost 
Age group Healthy slaughter Risk animals 
<24 months 152 3 
24-29 months 137 20 
30-35 months 302 29 
36-41 months 138 18 
42-47 months 108 15 
All <48 months 836 86 
All Ages 1.612 223 
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Table 5: costs (Mio €) per BSE case detected between January 2001 until December 2004 
Age group Healthy slaughter Risk animals 
<24 months No cases No cases 
24-29 months No cases 10,2 
30-35 months 302 29,5 
36-41 months 69 17,8 
42-47 months 11 0,9 
All <48 months 64 4,3 
All =>48 months 0,76 0,04 
All Ages 1,56 0,07 
 
